New Acting US FDA Commissioner Shares Agency's Clinical Trial Reform Message
Norman Sharpless, director of the National Cancer Institute, will become acting FDA commissioner when Scott Gottlieb departs.
You may also be interested in...
Hahn May Not Run Into Questions About Industry Ties Like His Predecessors
Nominee for US FDA commissioner has remained largely focused on academic work and private practice, receiving only a few payments from pharma and device companies.
US FDA Commissioner Transition: Sharpless Audition Is Ending – Will He Get The Part?
Ned Sharpless has been acting head of the US FDA for five months but has not yet been formally nominated for the permanent post. The emergence of another new name as a possible candidate underscores how uncertain the transition still is.
Acting Normal: US FDA's Unusual Interim Period Drags On
The messaging around the US FDA commissioner transition has emphasized continuity and business-as-usual. But this is still all pretty weird.